Statistics for MALDI-TOF MS-based urinary proteomic/peptidomic signature of breast cancer as innovative diagnostic approach
Total visits
views | |
---|---|
MALDI-TOF MS-based urinary proteomic/peptidomic signature of breast cancer as innovative diagnostic approach | 190 |
Total visits per month
views | |
---|---|
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
May 2025 | 1 |
June 2025 | 0 |
July 2025 | 0 |
File Visits
views | |
---|---|
Relatório.pdf(legacy) | 53 |
Relatório.pdf | 2 |
Top country views
views | |
---|---|
Germany | 70 |
Ukraine | 47 |
United Kingdom | 21 |
Portugal | 18 |
United States | 14 |
Israel | 4 |
Brazil | 3 |
Iran | 2 |
Japan | 2 |
Austria | 1 |
China | 1 |
Ireland | 1 |
Italy | 1 |
South Korea | 1 |
Luxembourg | 1 |
Malaysia | 1 |
Pakistan | 1 |
Qatar | 1 |
Saudi Arabia | 1 |
Top city views
views | |
---|---|
Luxembourg | 1 |